fda bpc 157 warning letter unapproved drug issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA mulls compounding for peptides
Description
Prescription options can be invasive, expensive, or come with side effects

Biomolecules 14:926

The criteria renal injury was based on the degeneration of Bowmans space and glomeruli, degeneration of the proximal and distal tubules, vascular congestion, and interstitial edema (Gojkovic et al., 2021a
Luckily I work from home and got my first dose on a Friday so Ive been able to mostly do what my body is telling me it needs
They are convenient and shipped to me directly
